| abstract |
The present invention provides a compound of formula I or II or a pharmaceutically acceptable salt form thereof, wherein R<1>, R<2>, R<3>, R<4>, R<5>, A<1>, A<2>, A<3>, A<4>, and A<5>, are as defined herein. The compounds of formula I or II have ALK and/or c-Met inhibitory activity, and may be used to treat proliferative disorders. |